Predicting Diagnostic Gene Biomarkers for Non-Small-Cell Lung Cancer

被引:9
|
作者
Liang, Bin [1 ]
Shao, Yang [1 ]
Long, Fei [1 ]
Jiang, Shu-Juan [1 ]
机构
[1] Shandong Univ, Shandong Prov Hosp, Dept Resp Med, Jinan 250021, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
EXPRESSION; NETWORK; GEMCITABINE; PROTEINS; DATABASE; PATHWAY; RISK;
D O I
10.1155/2016/3952494
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Lung cancer is the primary reason for death due to cancer worldwide, and non-small-cell lung cancer (NSCLC) is the most common subtype of lung cancer. Most patients die from complications of NSCLC due to poor diagnosis. In this paper, we aimed to predict gene biomarkers that may be of use for diagnosis of NSCLC by integrating differential gene expression analysis with functional association network analysis. We first constructed an NSCLC-specific functional association network by combining gene expression correlation with functional association. Then, we applied a network partition algorithm to divide the network into gene modules and identify the most NSCLC-specific gene modules based on their differential expression pattern in between normal and NSCLC samples. Finally, from these modules, we identified genes that exhibited the most impact on the expression of their functionally associated genes in between normal and NSCLC samples and predicted them as NSCLC biomarkers. Literature review of the top predicted gene biomarkers suggested that most of them were already considered critical for development of NSCLC.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Biomarkers of response to gefitinib in non-small-cell lung cancer
    Carbone, David P.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 66 - 67
  • [2] Potential biomarkers for immunotherapy in non-small-cell lung cancer
    Wang, Xing
    Qiao, Ziyun
    Aramini, Beatrice
    Lin, Dong
    Li, Xiaolong
    Fan, Jiang
    CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 661 - 675
  • [3] Biomarkers of response to gefitinib in non-small-cell lung cancer
    David P Carbone
    Nature Clinical Practice Oncology, 2004, 1 : 66 - 67
  • [4] Potential biomarkers for immunotherapy in non-small-cell lung cancer
    Xing Wang
    Ziyun Qiao
    Beatrice Aramini
    Dong Lin
    Xiaolong Li
    Jiang Fan
    Cancer and Metastasis Reviews, 2023, 42 : 661 - 675
  • [5] Gene fusions in non-small-cell lung cancer
    Yang, Lu-Lu
    Wu, Yi-Long
    LUNG CANCER MANAGEMENT, 2012, 1 (04) : 283 - 292
  • [6] Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
    Liao, Jipei
    Yu, Lei
    Mei, Yuping
    Guarnera, Maria
    Shen, Jun
    Li, Ruiyun
    Liu, Zhenqiu
    Jiang, Feng
    MOLECULAR CANCER, 2010, 9
  • [7] Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer
    Jipei Liao
    Lei Yu
    Yuping Mei
    Maria Guarnera
    Jun Shen
    Ruiyun Li
    Zhenqiu Liu
    Feng Jiang
    Molecular Cancer, 9
  • [8] Biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer
    Fuschillo, Salvatore
    Battiloro, Ciro
    Rocco, Danilo
    D Gravara, Luigi
    Motta, Andrea
    Maniscalco, Mauro
    BIOMARKERS IN MEDICINE, 2020, 14 (11) : 929 - 932
  • [9] Identifying successful biomarkers for patients with non-small-cell lung cancer
    Friedlaender, Alex
    Bauml, Joshua
    Banna, Giuseppe Luigi
    Addeo, Alfredo
    LUNG CANCER MANAGEMENT, 2019, 8 (03)
  • [10] Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
    S A Belinsky
    M J Grimes
    E Casas
    C A Stidley
    W A Franklin
    T J Bocklage
    D H Johnson
    J H Schiller
    British Journal of Cancer, 2007, 96 : 1278 - 1283